Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2082 |  ABSI Absci Corporation - Common Stock | 10.91 USD | -3.71% | -5.38% | +62.59% | +307.09% | 1.70 B USD | ||
| 2097 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 28.13 USD | +1.63% | +5.75% | +58.12% | +6.31% | 1.78 B USD | ||
| 2101 |  AAPG Ascentage Pharma Group International - American Depository Shar | 18.40 USD | -1.50% | +3.37% | +7.35% | -26.40% | 1.72 B USD | ||
| 2109 |  VIR Vir Biotechnology, Inc. - Common Stock | 10.35 USD | +0.98% | +2.37% | +20.07% | +73.08% | 1.75 B USD | ||
| 2120 |  IMCR Immunocore Holdings plc - American Depositary Shares | 33.16 USD | -0.72% | +4.02% | +17.71% | -0.96% | 1.69 B USD | ||
| 2131 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 37.47 USD | +1.11% | +7.30% | +25.61% | +97.21% | 1.70 B USD | ||
| 2139 |  GHRS GH Research PLC - Ordinary Shares | 26.76 USD | -0.48% | -0.59% | +30.92% | +88.98% | 1.66 B USD | ||
| 2145 |  FTRE Fortrea Holdings Inc. - Common Stock | 17.10 USD | -2.17% | -4.26% | +0.59% | +254.04% | 1.62 B USD | ||
| 2151 |  INVA Innoviva, Inc. - Common Stock | 22.30 USD | +0.22% | -1.20% | -1.02% | +25.14% | 1.65 B USD | ||
| 2161 |  SEPN Septerna, Inc. - Common Stock | 36.13 USD | +0.84% | +6.48% | +17.73% | +64.15% | 1.63 B USD | ||
| 2170 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 34.38 USD | +0.59% | -1.38% | +10.76% | +66.81% | 1.60 B USD | ||
| 2180 |  NVAX Novavax, Inc. - Common Stock | 9.41 USD | -0.53% | -1.16% | +7.54% | +31.42% | 1.55 B USD | ||
| 2183 |  XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.78 USD | -1.79% | +10.72% | +40.48% | +79.92% | 1.52 B USD | ||
| 2190 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 5.79 USD | -2.20% | -7.80% | +14.20% | +106.79% | 1.49 B USD | ||
| 2208 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 97.12 USD | -3.60% | -5.01% | +6.73% | +20.53% | 1.42 B USD | ||
| 2235 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 19.13 USD | -0.10% | -3.38% | +4.59% | +100.10% | 1.41 B USD | ||
| 2259 |  IMTX Immatics N.V. - Ordinary Shares | 10.41 USD | +1.46% | +3.58% | +10.74% | +0.58% | 1.40 B USD | ||
| 2274 |  MGTX MeiraGTx Holdings plc - Ordinary Shares | 14.67 USD | +0.07% | +9.15% | +61.21% | +67.66% | 1.36 B USD | ||
| 2281 |  ARDX Ardelyx, Inc. - Common Stock | 5.40 USD | +0.37% | +4.45% | -4.42% | +20.27% | 1.33 B USD | ||
| 2291 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 16.15 USD | +3.33% | +3.59% | +43.68% | +306.80% | 1.36 B USD |
Nouvelles Biotechnology Stocks
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Nurix Therapeutics : les résultats sous l’œil de l’accord avec Roche
L’action Edgewise Therapeutics atteint un sommet historique à 43,96 $
Stifel abaisse la note de Crinetics à Conserver après l’acquisition par Vertex
Gainers Biotechnology Stocks
 APLMW Apollomics Inc. - Warrant | 0.0184 | +53.33% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 PRME Prime Medicine, Inc. - Common Stock | 4.68 | +17.29% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.17 | +13.21% |
 ANVS Annovis Bio, Inc. Common Stock | 2.16 | +11.92% |
 BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.27 | +11.82% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
 ELOX Eloxx Pharmaceuticals, Inc. | 12.01 | +9.68% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0133 | -20.83% |
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.31 | -16.61% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 PHGE BiomX Inc. COmmon Stock | 0.26 | -13.33% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1053 | -11.21% |
 ICUCW SeaStar Medical Holding Corporation - Warrant | 0.0204 | -10.92% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.44 | -10.20% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.34 | -9.83% |